EDMONTON, Alberta--(EON: Enhanced Online News)--NanoSpeed has reached sales of over 200,000 units of its Test4D™ – Vitamin D deficiency test kit - since the launch of the product in April 2013.
“which include convenience, cost and reliability of the test that can empower the end-user to manage their own health. We look forward to continuing to successfully commercialize and validate our diagnostic technology with future products.”
“The response from the global market for a point-of-care vitamin D diagnostic in hospitals, physician’s offices and remote areas has been tremendous,” said Dr. Seema Gupta, President of NanoSpeed Diagnostics, Inc., a leading diagnostics company focused on providing portable, innovative and rapid testing solutions. “This significant milestone in the sale of Test4D™ has directly provided physicians and patients with immediate information to help them to manage their own health and well-being with respect to vitamin D deficiency.”
Test4D™ is a patented and unique point-of-care test that provides information on Vitamin D deficiency within 10 minutes. This test requires only a single drop of blood from the patient and costs 90% less when compared to other standard or conventional tests.
“Our partners attribute the success of Test4D™ to three factors,” Gupta adds, “which include convenience, cost and reliability of the test that can empower the end-user to manage their own health. We look forward to continuing to successfully commercialize and validate our diagnostic technology with future products.”
About NanoSpeed Diagnostics Inc.
NanoSpeed, incorporated in 2009, develops proprietary diagnostic/screening test kit platforms based on their Lateral Flow Immuno Assay and Lab-On-a-Chip technologies. These technological advancements provide patients with cost effective and reliable testing tools that will address the increasing needs of the healthcare industry, regulatory agencies and consumers.
About Vitamin D deficiency and Test4D™:
Vitamin D deficiency is a common problem in Canada, where 60% of adults have suboptimal levels of 25-OH vitamin D. It has been found that vitamin D deficiency is associated with abnormalities in absorption of calcium, phosphorus, and bone metabolism; cardiovascular disease; diabetes; cancer; osteomalacia and osteoporosis in adults; and rickets in children. Deficient vitamin D levels are the result of the body not receiving adequate intake of vitamin D through sunlight, diet, or supplements in addition to malabsorptive disorders.
25-OH vitamin D levels are currently identified through laboratory testing. Over the past decade, there has been an incremental surge in the demand for vitamin D testing, resulting in an overload of testing requirements for laboratories as well as surging costs to both laboratories and the government. An alternative to laboratory testing is Point-of-Care-Testing (POCT), medical testing that occurs outside of a clinical laboratory and near the patient. Potential advantages of POCT include reduction in errors and cost to the healthcare system, and the provision of quick and accurate clinical diagnosis due to the availability of results.
To address the demands of vitamin D testing on laboratories and the government, NanoSpeed Diagnostics Inc. developed Test4D™, a POCT device for the qualitative detection of 25-OH Vitamin D in human blood obtained via fingertip puncture.
Test4D™ is available for commercial sale through certain distributors, or can be purchased for research purposes directly from NanoSpeed.